DYRK1A inhibitors for disease therapy: Current status and perspectivesTong Liu, Jifa Zhang, Hao Chen et al.|European Journal of Medicinal Chemistry|2021Cited by 103
Preclinical reserpine models recapitulating motor and non-motor features of Parkinson’s disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairmentYang Li, Tong Liu|Frontiers in Pharmacology|2022Cited by 29
Resolvin D1/N-formyl peptide receptor 2 ameliorates paclitaxel-induced neuropathic pain through the activation of IL-10/Nrf2/HO-1 pathway in miceCunjin Su, Tong Liu|Frontiers in Immunology|2023Cited by 26
IDH2-mediated regulation of the biogenesis of the oxidative phosphorylation systemAnjaneyulu Murari, Edward Owusu-Ansah, Naga Sri Goparaju et al.|Science Advances|2022Cited by 25
Astrocyte PERK and IRE1 Signaling Contributes to Morphine Tolerance and Hyperalgesia through Upregulation of Lipocalin-2 and NLRP3 Inflammasome in the Rodent Spinal CordBing Wang, Tong Liu|Anesthesiology|2023Cited by 20